Aptalis Holdings (APTA) Acquired

Develops and markets therapies for cystic fibrosis and gastrointestinal disorders.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Aptalis Holdings IPO News more
  • .
IPO Data
IPO File Date 12/26/2013
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $500
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$500
 
Underwriters
more
Business Overview
Develops and markets therapies for cystic fibrosis and gastrointestinal disorders.
Develops and markets therapies for cystic fibrosis and gastrointestinal disorders.
more
Company Data
Headquarters Bridgewater, NJ
Founded 1982
Employees 961
Website www.AptalisPharma.com
 

Performance vs. IPO Index (IPOUSA)